Table 2 DFS and OS events stratified by different groups
|  | Overall n = 3761 (%) | HER2-neg n = 3313 (%) | HER2-pos-T n= 448 (%) |
|---|---|---|---|
DFS events | Â | Â | Â |
No recurrence | 3318 (88.2) | 2911 (87.9) | 407 (90.8) |
Local-regional recurrence | 73 (1.9) | 63 (1.9) | 10 (2.2) |
Contralateral breast cancer | 38 (1.0) | 36 (1.0) | 2 (0.5) |
Second non-breast malignancy | 56 (1.5) | 52 (1.6) | 4 (1.0) |
Distant recurrence | 198 (5.3) | 179 (5.4) | 19 (4.2) |
Death without recurrence | 78 (2.1) | 72 (2.2) | 6 (1.3) |
OS events | Â | Â | Â |
Alive | 3570 (94.9) | 3136 (94.7) | 434 (96.9) |
Death of any cause | 191 (5.1) | 177 (5.3) | 14 (3.1) |
Death with recurrence | 123 (3.0) | 105 (3.1) | 8 (1.8) |
Death without recurrence | 78 (2.1) | 72 (2.2) | 6 (1.3) |